166 related articles for article (PubMed ID: 17234210)
1. The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement.
Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
J Mol Biol; 2007 Mar; 367(1):224-33. PubMed ID: 17234210
[TBL] [Abstract][Full Text] [Related]
2. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
[TBL] [Abstract][Full Text] [Related]
3. Structure of complement component C2A: implications for convertase formation and substrate binding.
Milder FJ; Raaijmakers HC; Vandeputte MD; Schouten A; Huizinga EG; Romijn RA; Hemrika W; Roos A; Daha MR; Gros P
Structure; 2006 Oct; 14(10):1587-97. PubMed ID: 17027507
[TBL] [Abstract][Full Text] [Related]
4. Formation of high affinity C5 convertase of the classical pathway of complement.
Rawal N; Pangburn MK
J Biol Chem; 2003 Oct; 278(40):38476-83. PubMed ID: 12878586
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
Ponnuraj K; Xu Y; Macon K; Moore D; Volanakis JE; Narayana SV
Mol Cell; 2004 Apr; 14(1):17-28. PubMed ID: 15068800
[TBL] [Abstract][Full Text] [Related]
6. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.
Kuttner-Kondo LA; Dybvig MP; Mitchell LM; Muqim N; Atkinson JP; Medof ME; Hourcade DE
J Biol Chem; 2003 Dec; 278(52):52386-91. PubMed ID: 14561755
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
Fujita T; Inoue T; Ogawa K; Iida K; Tamura N
J Exp Med; 1987 Nov; 166(5):1221-8. PubMed ID: 2445886
[TBL] [Abstract][Full Text] [Related]
8. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
9. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
Rawal N; Rajagopalan R; Salvi VP
J Biol Chem; 2008 Mar; 283(12):7853-63. PubMed ID: 18204047
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
11. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
Thielens NM; Colomb MG
Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
[TBL] [Abstract][Full Text] [Related]
12. The human complement system: assembly of the classical pathway C3 convertase.
Kerr MA
Biochem J; 1980 Jul; 189(1):173-81. PubMed ID: 6906228
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement.
Mortensen S; Kidmose RT; Petersen SV; Szilágyi Á; Prohászka Z; Andersen GR
J Immunol; 2015 Jun; 194(11):5488-96. PubMed ID: 25911760
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of complement C5 convertase enzymes.
Pangburn MK; Rawal N
Biochem Soc Trans; 2002 Nov; 30(Pt 6):1006-10. PubMed ID: 12440962
[TBL] [Abstract][Full Text] [Related]
15. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
16. Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.
Mortensen S; Jensen JK; Andersen GR
J Biol Chem; 2016 Aug; 291(32):16494-507. PubMed ID: 27252379
[TBL] [Abstract][Full Text] [Related]
17. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
Janssen BJ; Gomes L; Koning RI; Svergun DI; Koster AJ; Fritzinger DC; Vogel CW; Gros P
EMBO J; 2009 Aug; 28(16):2469-78. PubMed ID: 19574954
[TBL] [Abstract][Full Text] [Related]
18. Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.
Laursen NS; Andersen KR; Braren I; Spillner E; Sottrup-Jensen L; Andersen GR
EMBO J; 2011 Feb; 30(3):606-16. PubMed ID: 21217642
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
Nagasawa S; Stroud RM
Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
[TBL] [Abstract][Full Text] [Related]
20. Structural biology of the alternative pathway convertase.
Xu Y; Narayana SV; Volanakis JE
Immunol Rev; 2001 Apr; 180():123-35. PubMed ID: 11414354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
